产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
名称 | 8305C (人甲状腺癌细胞(未分化)) (STR鉴定正确) |
别称 | 8305c; 8305-C; 8305C_1 |
种属 | 人 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:3-1:5 |
推荐换液频率 | 2-3次/周 |
背景描述 | Established from the primary tumor of a 67-year-old woman with primary thyroid carcinoma (undifferentiated carcinoma, composed of spindle, polygonal and giant cells) |
年龄(性别) | 女性;67岁 |
组织来源 | 甲状腺癌 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 甲状腺癌细胞 |
生物安全等级 | BSL-1 |
倍增时间 | ~54 hours (DSMZ); 43 hours (ECACC); ~43 hours (ICLC) |
保藏机构 | DSMZ; ACC-133 ECACC; 94090183 JCRB; JCRB0824 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 9,12 D2S1338 17,25 D3S1358 15 D5S818 10,13 D7S820 8,10 D8S1179 11,14 D13S317 9 D16S539 10,11 D18S51 13,24 D19S433 14 D21S11 30,32.2 FGA 21,22 PentaD 10 PentaE 15,17 TH01 6,7 TPOX 8 vWA 14,16 D6S1043 13 D12S391 19,25 D2S441 11,12 -
STR鉴定图
-
参考文献
-
DNMT1/DNMT3a-mediated promoter hypermethylation and transcription activation of ICAM5 augments thyroid carcinoma progression (2024-01-17)
期刊:FUNCTIONAL & INTEGRATIVE GENOMICS
DOI:10.1007/s10142-024-01293-3
影响因子 :2.9
引用产品: B-CPAP [BC-PAP; BCPAP] 细胞 , 8305C 细胞 , BHT101 细胞 , CAL-62 细胞
-
RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex (2023-02-21)
期刊:Cell and Bioscience
DOI:10.1186/s13578-023-00987-8
影响因子 :7.5
引用产品: TPC-1 细胞 , B-CPAP [BC-PAP; BCPAP] 细胞 , KTC-1 细胞 , C643 细胞 , CAL-62 细胞 , 8305C 细胞 , KMH-2 细胞 , KHM-5M 细胞 , BHT101 细胞
-
Redox/pH-responsive hollow manganese dioxide nanoparticles for thyroid cancer treatment (2023-09-15)
期刊:Frontiers in Chemistry
DOI:10.3389/fchem.2023.1249472
影响因子 :5.5
引用产品: 8305C 细胞
-
pH-responsive MTX-BSA@MnO2-Cy5.5 for NIRF/MR imaging guided chemotherapy of anaplastic thyroid carcinoma (2023-09-17)
期刊:JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
DOI:10.1016/j.jddst.2023.104960
影响因子 :5.0
-
Receptor Type Protein Tyrosine Phosphatase Epsilon (PTPRE) Plays an Oncogenic Role in Thyroid Carcinoma by Activating the AKT and ERK1/2 Signaling Pathway (2023-07-01)
期刊:CURRENT CANCER DRUG TARGETS
DOI:10.2174/1568009623666230118111745
影响因子 :3.0
-
Tripartite motif containing 63, regulated by E26 transformation specific variant 4, facilitates the thyroid carcinoma progression and the AKT, p38, and ERK signaling pathways (2004-02-20)
期刊:MOLECULAR AND CELLULAR ENDOCRINOLOGY
影响因子 :4.1
FAQs
Q:{{item.question}}
A:
产品资料


识别码示意图